• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK / ANIKA THERAPEUTICS, INC. ORTHOVISC 30MG/2ML SYR ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK / ANIKA THERAPEUTICS, INC. ORTHOVISC 30MG/2ML SYR ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Insufficient Information (4580)
Event Date 10/11/2021
Event Type  Injury  
Event Description
Patient reported that she has surgery on the right knee on (b)(6) 2021 and is on naproxen, as needed patient declined to be transfer to the rph for clinical consultations but was encourage and advised to give (b)(6) a call if she wants to speak with the rph for any clinical consultations. This will be (b)(6) first fill for the patient. Md. (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameORTHOVISC 30MG/2ML SYR
Type of DeviceACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
DEPUY MITEK / ANIKA THERAPEUTICS, INC.
MDR Report Key12813352
MDR Text Key280872053
Report NumberMW5105293
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes

Patient Treatment Data
Date Received: 11/12/2021 Patient Sequence Number: 1
Treatment
ETODOLAC
-
-